Medeon Biodesign, Inc. (TPEX:6499)
41.30
+0.10 (0.24%)
Feb 21, 2025, 1:30 PM CST
Medeon Biodesign Revenue
Medeon Biodesign had revenue of 104.79M TWD in the quarter ending September 30, 2024, with 129.19% growth. This brings the company's revenue in the last twelve months to 270.93M, up 52.47% year-over-year. In the year 2023, Medeon Biodesign had annual revenue of 196.26M, down -34.21%.
Revenue (ttm)
270.93M
Revenue Growth
+52.47%
P/S Ratio
14.04
Revenue / Employee
6.95M
Employees
39
Market Cap
3.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
Dec 31, 2020 | 123.06M | -330.71M | -72.88% |
Dec 31, 2019 | 453.76M | -219.77M | -32.63% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |